CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Acclarent, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Acclarent, Inc.
1525 Obrien Dr, Ste B
Phone: (650) 687-5888p:650 687-5888 MENLO PARK, CA  94025  United States Fax: (650) 687-5889f:650 687-5889

This company was Merged or Acquired on 1/20/2010.
This is a Subsidiary, click here for the Parent Company

Business Summary
Acclarent, Inc. is a medical device company. The Company is engaged in developing minimally invasive technologies that help patients, and invests in clinical studies and physician training. It is focused on meeting the needs of ear, nose and throat (ENT) patients. The Company is focused on a range of health conditions, which include Sinusitis, Pediatric rhinosinusitis and Airway stenosis. The Company's products include Balloon Sinuplasty Systems, Ethmoid Punch and Airway Dilation System. The Company also offers practice solutions, including Balloon Sinuplasty In-Office, General Balloon Sinuplasty and Pediatric Balloon Sinuplasty. The Balloon Sinuplasty system uses endoscopic techniques and enables qualified Otolaryngologists to dilate obstructed sinus ostia in patients suffering from sinusitis. The Company's Ethmoid Punch product includes RELIEVA CIRCA Ethmoid Punch. Its Airway Dilation Systems include INSPIRA AIR Balloon Dilation System and ACCLARENT Balloon Inflation Device.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/200812/31/2007YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board JoshuaMakower 54 11/1/2004 6/1/2004
President, Chief Executive Officer, Director William M.Facteau 43 11/1/2004 11/1/2004
Chief Financial Officer George A.Harter 62 9/1/2005 9/1/2005
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 210 (As of 4/30/2008)
Federal Tax Id: 201772549
Fax Number: (650) 687-5889
Email Address: customerservice@acclarent.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023